SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-503435
Filing Date
2016-03-14
Accepted
2016-03-14 16:08:00
Documents
80
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d124615d10k.htm 10-K 1086717
2 EX-10.6 d124615dex106.htm EX-10.6 7965
3 EX-10.7 d124615dex107.htm EX-10.7 36974
4 EX-23.1 d124615dex231.htm EX-23.1 1516
5 EX-31.1 d124615dex311.htm EX-31.1 8367
6 EX-31.2 d124615dex312.htm EX-31.2 8361
7 EX-32.1 d124615dex321.htm EX-32.1 4261
8 EX-32.2 d124615dex322.htm EX-32.2 4255
15 GRAPHIC g124615g18l38.jpg GRAPHIC 109697
  Complete submission text file 0001193125-16-503435.txt   5695686

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aqxp-20151231.xml EX-101.INS 924095
10 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20151231.xsd EX-101.SCH 59758
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20151231_cal.xml EX-101.CAL 83813
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20151231_def.xml EX-101.DEF 220442
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20151231_lab.xml EX-101.LAB 526090
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20151231_pre.xml EX-101.PRE 388342
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36327 | Film No.: 161503900
SIC: 2834 Pharmaceutical Preparations